DWJ 1355
Alternative Names: DWJ1355Latest Information Update: 28 Feb 2019
At a glance
- Originator Daewoong Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for research development in Thrombosis in South Korea
- 22 Jan 2015 Early research in Thrombosis in South Korea (unspecified route) before January 2015